Header

UZH-Logo

Maintenance Infos

Barriers to Accrual and Enrollment in Brain Tumor Trials


Lee, Eudocia Q; Chukwueke, Ugonma N; Hervey-Jumper, Shawn L; et al; Weller, Michael (2019). Barriers to Accrual and Enrollment in Brain Tumor Trials. Neuro-Oncology, 21(9):1100-1117.

Abstract

Many factors contribute to the poor survival of malignant brain tumor patients, some of which are not easily remedied. However, one contributor to the lack of progress that may be modifiable is poor clinical trial accrual. Surveys of brain tumor patients and neuro-oncology providers suggest that clinicians do a poor job of discussing clinical trials with patients and referring patients for clinical trials. Yet, data from the Cancer Action Network of the American Cancer Society suggest that most eligible oncology patients asked to enroll on a clinical trial will agree to do so. To this end, the Society for Neuro-Oncology (SNO) in collaboration with the Response Assessment in Neuro-Oncology (RANO) Working Group, patient advocacy groups, clinical trial cooperative groups including the Adult Brain Tumor Consortium (ABTC), and other partners are working together with the intent to double clinical trial accrual over the next five years. Here we describe the factors contributing to poor clinical trial accrual in neuro-oncology and offer possible solutions.

Abstract

Many factors contribute to the poor survival of malignant brain tumor patients, some of which are not easily remedied. However, one contributor to the lack of progress that may be modifiable is poor clinical trial accrual. Surveys of brain tumor patients and neuro-oncology providers suggest that clinicians do a poor job of discussing clinical trials with patients and referring patients for clinical trials. Yet, data from the Cancer Action Network of the American Cancer Society suggest that most eligible oncology patients asked to enroll on a clinical trial will agree to do so. To this end, the Society for Neuro-Oncology (SNO) in collaboration with the Response Assessment in Neuro-Oncology (RANO) Working Group, patient advocacy groups, clinical trial cooperative groups including the Adult Brain Tumor Consortium (ABTC), and other partners are working together with the intent to double clinical trial accrual over the next five years. Here we describe the factors contributing to poor clinical trial accrual in neuro-oncology and offer possible solutions.

Statistics

Citations

Dimensions.ai Metrics
6 citations in Web of Science®
9 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

7 downloads since deposited on 30 Oct 2019
6 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Oncology
Health Sciences > Neurology (clinical)
Life Sciences > Cancer Research
Language:English
Date:6 September 2019
Deposited On:30 Oct 2019 15:42
Last Modified:01 Dec 2020 13:06
Publisher:Oxford University Press
ISSN:1522-8517
OA Status:Hybrid
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/neuonc/noz104
PubMed ID:31175826

Download

Hybrid Open Access

Download PDF  'Barriers to Accrual and Enrollment in Brain Tumor Trials'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 351kB
View at publisher